Mindfulness for Reducing Colorectal Cancer Risk
(MindCRC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how practicing mindfulness might lower the risk of colorectal cancer, particularly for Black American women in Chicago who experience significant daily stress. Researchers believe stress can impact the gut and immune system, potentially increasing cancer risk. Participants will engage in an 8-week mindfulness program to assess its effectiveness. Women who have had a colonoscopy in the last two years and reside in high-crime areas in Chicago are encouraged to join. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance stress management and cancer prevention strategies.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it excludes those taking certain medications like β-blockers and corticosteroids. It's best to discuss your specific medications with the trial team.
What prior data suggests that mindfulness is safe for reducing colorectal cancer risk factors?
Research has shown that mindfulness is generally safe and easy to manage. Studies have found that it can lower stress, anxiety, and depression in cancer patients while boosting their overall quality of life. No reports of serious side effects from practicing mindfulness suggest it is a low-risk way to reduce stress and improve health.12345
Why are researchers excited about this trial?
Most treatments for reducing colorectal cancer risk focus on lifestyle changes like diet, exercise, and regular screenings. But mindfulness training offers a unique approach by targeting stress reduction and mental well-being, which can indirectly influence physical health. Researchers are excited about mindfulness because it emphasizes holistic health and doesn't require medications or invasive procedures. This technique might empower individuals to manage stress better, potentially lowering cancer risk through improved overall health.
What evidence suggests that mindfulness might be an effective treatment for reducing colorectal cancer risk?
Research has shown that mindfulness practices can reduce stress, anxiety, and depression in cancer patients. These benefits are crucial as they support better health and recovery. One study found that an online mindfulness program benefited individuals with breast, prostate, or colorectal cancer, suggesting it might help reduce cancer risk factors. Another review found that mindfulness programs improve the quality of life for cancer patients. This trial will evaluate an 8-week mindfulness program to determine if it can lower the risk of colorectal cancer by managing stress and its effects on the body.12467
Are You a Good Fit for This Trial?
This trial is for Black American women at an elevated risk of colorectal cancer who live in high-stress neighborhoods in Chicago. Participants should be interested in practicing mindfulness to potentially reduce their cancer risk.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Mindfulness Intervention
Participants undergo an 8-week mindfulness intervention delivered in a hybrid format, including both group and individual mindfulness training and practice.
Follow-up
Participants are monitored for changes in stress, weight, glucose, inflammation markers, and gut microbiome composition after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness
Mindfulness is already approved in United States, European Union, Canada for the following indications:
- Substance Abuse Treatment
- Anxiety Disorders
- Depression
- Stress Management
- Anxiety Disorders
- Chronic Pain
- Depression
- Anxiety Disorders
- Substance Abuse Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor